SIGN UP
LOG IN
MARKET
PPBT
PPBT
Purple Biotech Ltd
NASDAQ
1.030
-0.040
-3.74%
Closed 19:57 12/06 EST
OPEN
1.070
PREV CLOSE
1.070
HIGH
1.100
LOW
1.000
VOLUME
54.45K
TURNOVER
0
52 WEEK HIGH
2.370
52 WEEK LOW
0.8800
MARKET CAP
25.09M
P/E (TTM)
-0.9829
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PPBT last week (1127-1201)?
Weekly Report · 3d ago
Weekly Report: what happened at PPBT last week (1120-1124)?
Weekly Report · 11/27 09:46
Purple Biotech Ltd: Report of foreign issuer
Press release · 11/21 23:15
HC Wainwright & Co. Maintains Buy on Purple Biotech, Raises Price Target to $10
Benzinga · 11/21 18:45
Promising Clinical Trial Results and Accelerated Enrollment Boost Purple Biotech’s Buy Rating
TipRanks · 11/21 16:35
Purple Biotech: Q3 Earnings Insights
Purple biotech reported in-line q3 earnings of $-0.23. Purple biotech's revenue was down $0 from the same period last year. The company is expected to announce its earnings on november 21, 2023 at 06:50am. Last quarter the company beat by $0.01.
Benzinga · 11/21 12:00
Purple Biotech Q3 EPS $(0.23), Inline; $15.9M In Cash, Cash Equivalents And Short-term Deposits. In October 2023 The Company Raised An Additional Gross Amount Of $5M Extended The Cash Runway To The Second Half Of 2025
Benzinga · 11/21 11:56
Purple Biotech GAAP EPS of -$0.23
Tpurple biotech ltd. Reported q3 gaap eps of -$0.23. Purple biotech had $15.9 million in cash, cash equivalents and short-term deposits as of september 30, 2023. The company reported a net loss of $4.6 million for the quarter.
Seeking Alpha · 11/21 11:55
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Webull offers Purple Biotech Ltd - ADR stock information, including NASDAQ: PPBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading PPBT stock methods without spending real money on the virtual paper trading platform.